0001209191-21-006709.txt : 20210202 0001209191-21-006709.hdr.sgml : 20210202 20210202155541 ACCESSION NUMBER: 0001209191-21-006709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210131 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Jason Drew CENTRAL INDEX KEY: 0001821479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 21581272 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 400 ALEXANDER PARK DRIVE CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-31 0 0001668243 UroGen Pharma Ltd. URGN 0001821479 Smith Jason Drew C/O UROGEN PHARMA LTD. 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 0 1 0 0 General Counsel Stock Option (right to buy) 22.07 2021-01-31 4 A 0 8000 0.00 A 2031-01-30 Ordinary Shares 8000 8000 D Restricted Stock Units 2021-01-31 4 A 0 2500 0.00 A Ordinary Shares 2500 2500 D 1/3 of the shares underlying the stock option will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024. /s/ Jason D. Smith 2021-02-02